609.7

+1.84%↑

ALV

302.5

+0.27%↑

SAF

214.4

+2.49%↑

BBVA

9.088

-2.36%↓

65.16

-0.24%↓

609.7

+1.84%↑

ALV

302.5

+0.27%↑

SAF

214.4

+2.49%↑

BBVA

9.088

-2.36%↓

65.16

-0.24%↓

609.7

+1.84%↑

ALV

302.5

+0.27%↑

SAF

214.4

+2.49%↑

BBVA

9.088

-2.36%↓

65.16

-0.24%↓

609.7

+1.84%↑

ALV

302.5

+0.27%↑

SAF

214.4

+2.49%↑

BBVA

9.088

-2.36%↓

65.16

-0.24%↓

609.7

+1.84%↑

ALV

302.5

+0.27%↑

SAF

214.4

+2.49%↑

BBVA

9.088

-2.36%↓

65.16

-0.24%↓

Home・Stock List・Bayer AG

Bayer AG

Closed

Sector Finance

26.465 -0.32

Buy Sell

Overview

Share price change

24h

Current

Min

26.25

Max

26.56

Key metrics
By Trading Economics
Income	-2B -34M
Sales	-2.6B 11B
P/E Sector Avg	30.9 17.821
EPS	0.94
Profit margin	-0.305
EBITDA	-2.6B 1.7B

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+13.97 upside

Dividends
By Dow Jones
Next Earnings	12 Nov 2024

Market Stats
By TradingEconomics
Market Cap	-3.7B 26B
Previous open	26.79
Previous close	26.465

News Sentiment

By Acuity

33%

67%

128 / 461 Finance

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

26.13 / 26.685 Support & Resistance

Bayer AG Chart

Past performance is not a reliable indicator of future results.

Related News

9 Oct 2024, 17:03 UTC

Major Market Movers

Bayer Shares Plunge After U.S. Legal Setback -- Update

9 Oct 2024, 14:21 UTC

Major Market Movers

Bayer Shares Plunge After U.S. Legal Setback

16 Aug 2024, 08:28 UTC

Major Market Movers

Bayer Shares Surge After Appeal Win in Roundup Cancer Suit

15 Aug 2024, 21:43 UTC

Earnings

Bayer's Monsanto Wins Appeal in Roundup Cancer Suit

6 Aug 2024, 10:56 UTC

Earnings

Bayer Posts Net Loss as Tough Agriculture Market Bites -- Update

6 Aug 2024, 09:00 UTC

Earnings

Correction to Bayer Article

6 Aug 2024, 06:29 UTC

Earnings

Bayer Posts Net Loss, Dragged by Weaker Crop-Science Performance

14 May 2024, 13:21 UTC

Earnings

Bayer Plans More Job Cuts in Push for Fewer Bosses -- Update

23 Aug 2024, 08:51 UTC

Market Talk

BMW's EV Coup Over Tesla in Europe Shows Strength as Tesla Products Age -- Market Talk

16 Aug 2024, 14:21 UTC

Market Talk

Bayer's Appeal Win Could Be First Step to End Roundup Litigation -- Market Talk

16 Aug 2024, 08:58 UTC

Earnings

Hot Stocks

Stocks to Watch Friday: Applied Materials, H&R Block, Bayer, Bavarian Nordic -- WSJ

6 Aug 2024, 10:47 UTC

Market Talk

Bayer Could Face Consensus Earnings Downgrades Amid Currency Headwinds -- Market Talk

6 Aug 2024, 08:55 UTC

Market Talk

Earnings

Bayer's 2Q Beat Boosted By Pharma Business -- Market Talk

6 Aug 2024, 08:20 UTC

Market Talk

Earnings

Bayer's 2Q Results Are a Mixed Bag -- Market Talk

6 Aug 2024, 06:57 UTC

Market Talk

Earnings

Bayer 2Q Results Could Lead to Muted Share Price Response -- Market Talk

6 Aug 2024, 05:34 UTC

Earnings

Bayer Saw 2024 Core EPS Between EUR5.10 and EUR5.50

6 Aug 2024, 05:34 UTC

Earnings

Bayer Saw 2024 Ebitda Before Special Between EUR10.7B and EUR11.3B

6 Aug 2024, 05:33 UTC

Earnings

Bayer Backs 2024 View

6 Aug 2024, 05:33 UTC

Earnings

Analysts Saw Bayer 2Q Ebitda Before Special Items at EUR2.08B

6 Aug 2024, 05:33 UTC

Earnings

Bayer 2Q Ebitda Before Special Items EUR2.11B

6 Aug 2024, 05:32 UTC

Earnings

Analysts Saw Bayer 2Q Net Pft at EUR70M

6 Aug 2024, 05:32 UTC

Earnings

Bayer 2Q Net Loss EUR34M

6 Aug 2024, 05:31 UTC

Earnings

Analysts Saw Bayer 2Q Core EPS at EUR0.84

6 Aug 2024, 05:31 UTC

Earnings

Bayer 2Q Core EPS EUR0.94

6 Aug 2024, 05:31 UTC

Earnings

Bayer 2Q EBIT EUR525M

6 Aug 2024, 05:30 UTC

Earnings

Analysts Saw Bayer 2Q Rev at EUR10.82B

6 Aug 2024, 05:30 UTC

Earnings

Bayer 2Q Rev EUR11.14B

12 Jul 2024, 07:05 UTC

Market Talk

Bayer's Cost-Savings and Cash Delivery Key Focus for 2Q -- Market Talk

5 Jun 2024, 09:57 UTC

Hot Stocks

Stocks to Watch Wednesday: CrowdStrike, HPE, Dollar Tree -- WSJ

14 May 2024, 11:00 UTC

Market Talk

Earnings

Bayer Earnings Show Progression on Turnaround Strategy -- Market Talk

Peer Comparison

Price change

Bayer AG Forecast

Price Target

By TipRanks

13.97% upside

12 Months Forecast

Average 30.11 EUR 13.97%

High 34 EUR

Low 26 EUR

Based on 11 Wall Street analysts offering 12 month price targets forBayer AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Bayer AG - Dist in the past 3 months.

Technical Score

By Trading Central

26.13 / 26.685Support & Resistance

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

128 / 461 Finance

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

EBITDA

Operating profit

About Bayer AG

Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non